| Serial Number | 90864476 |
| Word Mark | ERUDITE STUDY |
| Filing Date | Wednesday, August 4, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Wednesday, July 31, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 14, 2022 |
| Goods and Services | Providing medical information; providing medical information relating to therapies and treatments for cognitive impairment associated with schizophrenia and mental illness and disorders |
| NOT AVAILABLE | "STUDY" |
| Goods and Services | Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of cognitive impairment associated with schizophrenia and mental illness and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of cognitive impairment associated with schizophrenia and mental illness and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of cognitive impairment associated with schizophrenia and mental illness and disorders, and evaluating epidemiological results for treatments for cognitive impairment associated with schizophrenia and mental illness and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for cognitive impairment associated with schizophrenia and mental illness and disorders |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 29, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 29, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Tuesday, May 3, 2022 | ASSIGNED TO EXAMINER |
| Saturday, August 7, 2021 | NEW APPLICATION ENTERED |
| Wednesday, September 29, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 5, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 5, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 5, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 5, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, May 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, May 9, 2022 | ASSIGNED TO LIE |
| Wednesday, May 25, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 14, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 14, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 9, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, February 6, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 6, 2023 | SOU EXTENSION 1 FILED |
| Monday, February 6, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, February 8, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, June 28, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 28, 2023 | SOU EXTENSION 2 FILED |
| Wednesday, June 28, 2023 | SOU EXTENSION 2 GRANTED |
| Friday, June 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 31, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 31, 2024 | SOU EXTENSION 3 FILED |
| Wednesday, January 31, 2024 | SOU EXTENSION 3 GRANTED |
| Wednesday, July 31, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 31, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 31, 2024 | SOU EXTENSION 4 FILED |
| Wednesday, July 31, 2024 | SOU EXTENSION 4 GRANTED |
| Friday, February 2, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |